| Views | |
|---|---|
| The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 223 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 7 | 3 | 1 | 1 | 3 | 0 | 1 |
| Views | |
|---|---|
| journal.pone.0182852.pdf | 171 |
